Mar 29, 2012 - Mar 29, 2014
This activity, sponsored by the Johns Hopkins University School of Medicine, will discuss the pathophysiology and definition of spasticity to aide in patient evaluation, assess the usefulness and limitations of various scales used for evaluation, and describe available treatments and clinically relevant distinctions in dosing and bioavailability between chemodenervation agents that are available for the management of spasticity in adults and children to help clinicians improve patient quality of life. Approved for a maximum of 0.5 AMA PRA Category 1 Credit(s)™

Jul 13, 2012 - Jul 12, 2015
Fatigue is the most commonly reported symptom in persons with Multiple Sclerosis. Fatigue interferes with sustained usual function, and is a significant cause of loss of employment and disability in otherwise unimpaired persons with MS. Despite its prevalence, primary MS fatigue is often under recognized and treated in the MS population. This course includes information about the presentation and mechanisms of MS fatigue, as well as treatment strategies for both primary MS fatigue and contributing factors. Approved for 1.0 CME. Sponsored by AAN.

Jul 18, 2012 - Jul 18, 2013
This activity is intended for neurologists, family medicine/primary care physicians, internists, and nurses. The goal of this activity is to apply emerging data from a recent national meeting on multiple sclerosis (MS) to clinical management of patients with MS. Upon completion of this activity, participants will be able to: 1.Assess new safety and efficacy data from the meetings on MS disease-modifying therapies 2.Compare and contrast the potential for emerging MS treatments to enhance treatment response Credits: Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

Aug 13, 2012 - Aug 13, 2013
Faculty: Francois Bethoux, MD; Priscilla Scherer, RN This activity is intended for neurologists, primary care providers, and nurses. The goal of this activity is to provide the multiple sclerosis (MS) care team with strategies for improving the assessment and management of MS symptoms affecting mobility and identify interventions to reduce the burden of MS mobility symptoms. Upon completion of this activity, participants will be able to: 1.Evaluate and use assessment strategies for the symptoms of MS that affect mobility 2.Select evidence-based strategies for improving symptoms of MS that affect mobility. Credits Available: Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™ . Nurses - 1.00 ANCC Contact Hour(s) (1 contact hours are in the area of pharmacology)

Aug 13, 2012 - Aug 13, 2013
Faculty: Francois Bethoux, MD; Susan E. Bennett, PT, DPT, EdD; Dorothea Cassidy Pfohl, RN; Priscilla Scherer, RN This activity is intended for neurologists, primary care providers, and nurses. The goal of this activity is to provide the MS care team with strategies for improving the assessment and management of MS symptoms affecting mobility, recognize the impact of these symptoms on patients, and identify interventions to reduce the burden of MS mobility symptoms. Upon completion of this activity, participants will be able to: 1.Compare and contrast techniques for assessing mobility impairments in patients with MS 2.Discuss evidence-based treatment strategies for improving symptoms of MS that affect mobility Credits: Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™ Nurses - 1.00 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

Oct 29, 2012 - Oct 29, 2013
Three experts provide their first impressions of new data on disease-modifying treatments presented at ECTRIMS 2012 in Lyon, France. Approved for .75 CME AMA PRA (Category 1).

Oct 31, 2012 - Oct 31, 2013
Corey C. Ford, MD, PhD; Edward J. Fox, MD, PhD Upon completion of this educational activity, the participant should be able to: •Review available safety and risk information applicable to current, new, and emerging disease-modifying therapy in MS; •Analyze the potential sources of safety concerns associated with disease-modifying therapies and utilize best practice guidelines for selecting and changing therapies ; •Educate patients about known safety risks and benefits of newer MS therapies and apply this information and other factors in therapeutic selection. 1.0 AMA PRA Category 1 Credits™

Dec 20, 2012 - Dec 20, 2013
Faculty: Andrew N. Wilner, MD; Robert P. Lisak, MD; Omar A. Khan, MD This activity is intended for neurologists, primary care physicians, physical medicine and rehabilitation specialists, nurse practitioners, physician assistants, and nurses. The goal of this activity is to discuss new data on disease-modifying therapies for treatment of multiple sclerosis (MS) presented at the 28th Congress of the European Committee for Treatment and Research in MS (ECTRIMS). Upon completion of this activity, participants will be able to: 1.Assess new safety and efficacy data on MS disease-modifying therapies 2.Describe how emerging MS treatments may be integrated into clinical practice 3.Determine the potential of meeting data on MS treatments to enhance treatment responses Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™

Jan 07, 2013 - Jan 07, 2014
This Virtual Patient simulation resource utilizes advanced 3D real-time technology that responds to your clinical decisions as you build a clinically definite MS diagnosis for each of three patients according to the 2010 McDonald Criteria. This activity is designed for neurologists, nurse practitioners, physician assistants, and other healthcare professionals who care for patients with MS. Objectives: · Incorporate the 2010 McDonald MS Diagnostic criteria into your MS diagnostic process. · Recognize and utilize key features of the neurologic examination and patient’s history that support the diagnosis of MS. · Increase your ability to apply neuroimaging findings correlate with disease activity and progression in MS to enhance your clinical judgments and treatment decisions Continuing Education Credits: Physicians: 2.0 AMA PRA Category 1 Credits™. Physician Assistants: AMA PRA Category 1 Credit(s)™ Nurse Practitioners: AMA PRA Category 1 Credit(s)™

Jun 07, 2013 - Jun 07, 2013
These monthly calls offer a forum for pediatric and adult neurologists across the country to discuss challenging diagnostic and treatment decisions involving children with MS and other CNS demyelinating disorders. Call in #:1-888-279-3775, pass code 0468# Webinar link: http://breeze50992852.adobeconnect.com/r447js8ywct/.

Mar 25, 2013 - Mar 25, 2014
The online formative assessment aims to provide clinicians with guidance from experts in the field, training to optimally assess the risks and benefits of MS therapies, and to enable the adoption of imaging and other instruments in their practice in order to better assess and manage patients with MS. Each of the five modules within this activity has their own learning objective. Upon completion of each of the modules, participants will be able to: •[Pathophysiology module]: Examine the basic tenets of MS immunology and recognize the scientific factors supporting the clinical management of MS •[Imaging assessment module]: Adopt improved diagnostic and assessment approaches in MS management that utilize advances in imaging technology and other screening tools •[Disease modification module]: Discuss the goals of MS treatment with patients; implement clinical algorithms for initial disease management and to improve outcomes •[Patient-centered care module]: Formulate and monitor treatment strategies for MS based on patient characteristics and preferences •[Symptom management]: Evaluate the safety and efficacy of pharmacologic treatment approaches for disease modification and symptom management Accredited for physicians and nurses. CME/CE accredited by module for physicians and nurses. SPonosred by COnsortium of MS Centers (CMSC)

May 22, 2013 - May 22, 2014
This 5-session series of webinars for OTs and PTs provides rehabilitation professionals with updated information on the diagnosis and treatment of MS and evidence-based rehabilitation management. The five topics covered are: - MS 101 - Spasticity and MS - Electrical Stimulation - Pain Management - Focus on OT. Each 1 hour webinar is approved for 1 hour continuing education credit in OK, AR, NM and TX. Free with discount code: NMSSOFF

May 29, 2013 - Jun 01, 2013
Our meeting is unique in bringing together all groups committed to improving the lives of people with MS: neurologists, radiologists, physiatrists, other medical specialists, clinical researchers, basic scientists, nursing professionals, rehabilitation specialists, counselors, members of the non-profit community and the corporate supporters whose driven many pharmaceutical and technological advances during the past two decades. The content of the meeting includes state-of-the-art information on the latest treatments, research, models of care, epidemiology, genetics, and much more. The CMSC is proud to partner with thousands of MS professionals who work in healthcare, community service, the pharmaceutical industry and education. Accredited for: physicians, nurses, pharamcists, social workers. Certificate of attendance provided for others.

Jun 17, 2013 - Jun 19, 2013
We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Neurology & Therapeutics. Neuro-2013 anticipates more than 500 participants around the globe with thought provoking Keynote lectures, Oral presentations and Poster presentations. The attending delegates include Editorial Board Members of related OMICS Group Journals. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The main theme of the conference is “Emerging Trends in Neurological Therapeutics” Highlights: - Plenary Session - Scientific/Speaker Sessions - Young Research Forum - Poster Presentations - Quality review process - Exhibitions and other Key Presentations. Who should attend Neuro-2013: • Neurologists • Neuro surgeons • Neurohospitalist • psychiatrists • Physician • Medical Practitioner • Professionals with M.D., D.O., and M.B.B.S • Students. Selected contributions will be published in following OMICS Group Journals: • Journal of Neurology & Neurophysiology • Journal of Alzeihmer’s Disease & Parkinsonism • Journal of Psychology & Psychotherapy

Jun 21, 2013 - Jun 21, 2013
Each year in this symposium we bring you both new information and ideas about MS and related diseases, as well as updates on key areas important for the care of MS patients. This year we will review new directions in the investigation of progressive MS, an area which has received less attention than it should considering the large number of people affected by it. We will look at our approach to managing risk in the MS population and how we may try to keep patients disease free, both of which bring new directions in personalized medicine to the MS arena. As always we will update you on new pharmacology for the MS patient, reflecting the great strides that have been made in the past few years. We will bring you updates on pediatric MS, the use of MRI in differential diagnosis of MS, assessments of gait and stress, and talks on diet and exercise. A unique part of the program will focus on the importance of your work/life balance in the scheme of taking care of a complex, psychologically challenging group of patients. Our keynote speaker this year is Dr. Steven Galetta, who will talk about “Optic Neuritis: Past, Present and Future”. Dr. Galetta specializes in MS and neuro-ophthalmology. This update is intended for physicians and other health care practitioners engaged in the care of patients with MS and related disorders. For further information about this activity, contact Monet Smith at Local: 216.444.9380; Toll Free: 800.223.2273 x49380; Email: smithm8@ccf.org

Jun 25, 2013 - Jun 25, 2013
Attention neurologists, physician assistants, nurses and other MS care providers! Join us for this professional education program intended to provide you with more timely, comprehensive care tips that fully supports your patients living with MS. We hope to offer CME credits for attendees, too. Featuring: > Fred Lublin, MD, the Saunders Family Professor of Neurology and the Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Medical Center. His presentation will focus on the treatment modalities available for people living with MS. > Phillip D. Rumrill, Jr., Ph.D., CRC, is a Professor of Rehabilitation Counseling and Director of the Center for Disabilities Studies at KSU. His presentation will focus on the unique employment needs of people with MS and how neurologists and other care professionals can support the unique options available for a person living with MS and remaining in the workforce. Dinner will be served. Parking and special seating available. There is no cost to attend but reservations are required. Please register by June 21 by calling 1-800-FIGHT-MS and pressing option 1. Registration will open early May

Oct 18, 2013 - Oct 19, 2013
This conference focuses on measurement tools for gait and balance in multiple sclerosis. The morning sessions will discuss measurement selection and quality, and include a session summarizing the latest data from the Rehabilitation in Multiple Sclerosis (RIMS) Special Interest Group on Mobility in Europe. The afternoon sessions will address specific impairments as they contribute to gait and balance dysfunction in people with MS. Physicians (Neurologists, Physiatrists), physical therapists, occupational therapists, rehabilitation scientists, nurses, and physician assistants working in the area of multiple sclerosis clinical practice or research.